Antiviral treatments are available to the 'Severely Immunosuppressed' a subset of the Clinically Vulnerable who remain at high-risk despite up to 5 vaccine doses.
๐งตwill cover how Vulnerable groups can access antiviral treatments. 1/
Early antiviral treatment is a vital tool to prevent severe outcomes in high-risk people.
Currently only a small group who have poor immunity following vaccination are allowed to access them.
Please look through this list to see if you qualify:
7. If you are told they only consider patients until day 6 or 7 refer them to this pathway.
By day 6/7 you would be limited to Remdesivir or 'off-label' (where a medicine used in a way different to that in the licence) access to the other treatments.
Weekend access is generally poor. It appears to be a postcode lottery.
We are worried about the availability of services over the upcoming 4 day Bank Holiday weekend.
Some areas will offer treatment on day 6/7, but this is far from optimal.
10/
8. If you are refused treatment and you do qualify you need to take it further try escalating within the hospital via your specialist team / PALS but be prepared to take it all the way to your local MP if all else fails by day 5.
We have heard that 10-15% of people who DO qualify can access these antiviral treatments.
Put another way, it means 85-90% can't access the antivirals.
We are highly concerned about this number!
12/
What if you are Clinically Vulnerable/50+ and DON'T qualify on the list?
The only possibility is accessing treatments via the Panoramic trial.
Lots of people can qualify for the trial but only 450 participants are added daily, of which only 225 are given the treatments.
13/
The demand has been high, due to the current surge.
However, this is currently closed for Easter...
It also appears to close over the weekends.
14/
The Panoramic trial has a screening process and either your GP, or a study nurse or doctor will assess your eligibility and ask for your consent.
If you do qualify you will have a 50:50 chance of being offered antivirals, which should arrive the next day.
15/
Even if you don't receive the antivirals you will need answer questions online for 28 days and answer 3 phone calls to discuss with the trial team on days 7, 14 & 28.
16/
We believe this constitutes health rationing.
Those 75+ should have been added to the antivirals list.
Plus, since treatments are already proven safe and effective for all Clinically Vulnerable / 50+, they should all have #Access2Antivirals through GPs and emergency GPs.
When the UK government rolled out the "Living with Covid" policy it simply scrapped protections and shifted to personal responsibility. For most, it meant "back to normal." For Clinically Vulnerable people, life became harder.
1/๐งต
The plan was based on a single assumption: that vaccines alone would be enough... vaccines due to be withdrawn this Autumn.
But for millions who are Clinically Vulnerable, vaccines werenโt a magic bullet. Protection wasnโt universal and some were left with little to none.
2/
๐Mask mandates ended
๐ฅFree tests were phased out
๐ฉโ๐ฉโ๐งโ๐ฆSelf-isolation was no longer required
Covid was treated as a personal problem, not a public health issue. If you got sick, you were on your own.
3/
๐ CVF are relieved to announce that we will be representing you in the final section of the UK Covid-19 Inquiry looking at the ๐๐บ๐ฝ๐ฎ๐ฐ๐ ๐ผ๐ป ๐ฆ๐ผ๐ฐ๐ถ๐ฒ๐๐.
It will consider the effects on keyworkers, vulnerable populations, bereaved, & mental health.
1/12 *Stick with this*
Protective measures were often described as "restrictions" and the lifting of measures described as the return of "freedom".
2/
๐ Seatbelts were once seen as a "restriction" by some, but today with evidence & awareness, they are now considered essential for safety.
๐จ๐ท The Covid pandemic was a missed opportunity to normalise airborne protections that protect health and save lives.
"Would you support the development of a more diverse portfolio of vaccine formats and antivirals, both as part of future pandemic preparedness plans and during [.] 'peace time' to ensure that Clinically Vulnerable groups are adequately protected?"
1/
"Absolutely, I think it is really important to make sure that we have good therapeutics and vaccines for the whole population."
2/
Q - Why is it important to have that breadth of formats?
...not many [immunosuppressed] were involved in the initial trials.
We now know [.] that booster doses help in terms of vaccine efficacy.
Find out more about what led to his reaction below โฌ๏ธ
1/๐งต
Do you agree that mRNA COVID-19 vaccine protection has been shown to wane after 5-6m?
WSL: Yes
Covid-19 has not transitioned into a seasonal virus like influenza?
WSL: Yes
If so, why did the JCVI not recommend more frequent vaccinations for all clinically vulnerable groups?
2/
To explain:
"Clinically Vulnerable" is defined by the JCVI in the vaccine Green Book. They are all those who qualify for annual autumn vaccines based on risk.
A small subset are also offered vaccines in spring. Those 75+, care home residents and severely immunosuppressed. 3/
๐จDame Kate Bingham๐จ
Dubbed the "hero in a pink jacket ๐"
On Evusheld:
"I felt very strongly [.]. We were following a very clear 2 tier strategy where the CV immunocompromised were being deprioritised [.] I felt that was *manifestly* wrong both ethically and morally [.]"
1/๐งต
The above video was taken out of sequence. The below should give more context...
KB "So actually, the first goal was around protecting the UK population."
CTI [Hugo Keith KC]
"Do you think you succeeded on securing or making available those monoclonal antibodies?"
KB "No!" 2/
Kate goes on to make the argument that by not protecting this population, we were also promoting viral mutation and the evolution of variants.